Otto II

Otto II is a hybrid cannabis strain with up to 0.8% THC, known for its relaxed effects and earthy and herbal flavor profile.

Otto II is a high-CBD, low-THC cannabis strain developed specifically for its therapeutic potential and minimal psychoactive effects. The strain was created through selective breeding of industrial hemp genetics, with a primary focus on maximizing cannabidiol (CBD) content while maintaining compliance with legal THC limits. Otto II represents a significant advancement in hemp cultivation, offering a consistent cannabinoid profile that makes it valuable for both medical research and commercial CBD extraction.

Visually, Otto II plants exhibit characteristics typical of industrial hemp varieties, with tall, slender structures and narrow leaves. The plants produce dense, resinous buds that are often light to medium green in color, sometimes with subtle purple hues depending on growing conditions. The strain's flowers are covered in trichomes, giving them a frosty appearance that indicates high cannabinoid production. Otto II is known for its vigorous growth and resilience, making it a popular choice for large-scale cultivation operations.

Notably, Otto II has gained recognition in the medical cannabis community for its consistent CBD-to-THC ratio, typically ranging from 20:1 to 30:1. This predictable cannabinoid profile has made it a preferred source for CBD extraction in various therapeutic products. The strain's development represents a shift toward standardized cannabis genetics for specific medical applications, though comprehensive clinical research on its effects remains limited.